Frühbehandlung der leichten Hypertonie

  • K. O. Stumpe

Zusammenfassung

Geringgradige Blutdruckerhöhungen werden relativ häufig und in allen Altersgruppen beobachtet. Eine einheitlich anerkannte Definition der sog. leichten Hypertonie fehlt, ebenso wie die Beantwortung der Frage, bis zu welchem Blutdruckwert eine Behandlung nicht erforderlich ist. Theoretisch müßte die Entscheidung zur Therapie durch die Höhe desjenigen Blutdruckwertes bestimmt werden, der das Risiko einer sog. Exzeßmorbidität und -mortalität zu einem zukünftigen Zeitpunkt in sich birgt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Alameda County Blood Pressure Study (1968) State of California, Department of Public Health, BerkeleyGoogle Scholar
  2. 2.
    Ames RP, Hill P (1976) Increase in serum-lipids during treatment of hypertension with chlorthalidone. Lancet 1: 721–723PubMedCrossRefGoogle Scholar
  3. 3.
    Davidson C, Thadani U, Singleton W, Taylor SH (1976) Comparison of beta-blocking drugs during chronic treatment. Brit Med J 3: 7–9CrossRefGoogle Scholar
  4. 4.
    Day JL, Simpson N, Metcalfe J et al. (1979) Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Brit med J 1: 77–80PubMedCrossRefGoogle Scholar
  5. 5.
    Dyer AR, Stamler J, Shekelle R, Schoenberger JA, Farinaro E (1977) Hypertension in the elderly. Med Clin North America 61: 513–529Google Scholar
  6. 6.
    Freis ED (1976) Salt, volume and the prevention of hypertension. Circulation 53: 589–595PubMedCrossRefGoogle Scholar
  7. 7.
    Gluck Z, Weidmann P, Mordasini R et al. (1979) Einfluß einer Diuretikatherapie auf die Serumlipoproteine: Ein unerwünschter Effekt? Schweiz med Wschr 109: 104–108PubMedGoogle Scholar
  8. 8.
    Goldman AI, Steele BW, Schnaper HW et al. (1980) Serum lipoprotein levels during chlorthalidone therapy. J Amer med Ass 244: 1691–1695CrossRefGoogle Scholar
  9. 9.
    Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H (1981) Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 94: 7–12PubMedGoogle Scholar
  10. 10.
    Hansson L, Werkö H (1977) Beta-adrenergic blockade in hypertension. Amer Heart J 93: 394–404PubMedCrossRefGoogle Scholar
  11. 11.
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. (1979) JAMA 242: 2562–71Google Scholar
  12. 12.
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex, and age. (1979) JAMA 242: 2572–77Google Scholar
  13. 13.
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure. (1982) JAMA 247: 633–38Google Scholar
  14. 14.
    Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in „mild“ hypertension. Results of the Hypertension Detection and Follow-up Program. (1982) New Engl J Med 307: 976–980Google Scholar
  15. 15.
    Kaplan NM (1981) Whom to treat: The dilemma of mild hypertension. Amer Heart J 101: 867–870PubMedCrossRefGoogle Scholar
  16. 16.
    Joos C, Kewitz H, Reinhold-Kourniati D (1980) Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmaco117: 251–257Google Scholar
  17. 17.
    Julius S (1977) Borderline hypertension. An Overview. Med Clin North America 61: 495–510Google Scholar
  18. 18.
    Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: The Framingham study. Dis Chest 56: 43–52Google Scholar
  19. 19.
    Kokubu T, Itoh I, Kurita H, Coni T, Murata K, Yuba I (1982) Effect of prazosin on serum lipids. J Cardiovasc Pharmacol 4: 228–232CrossRefGoogle Scholar
  20. 20.
    Leren P, Helgeland A, Holme J, Foss OP, Hjermann J, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4–6Google Scholar
  21. 21.
    Leren P, Foss OP, Helgeland A et al. (1981) Effects of pindolol and hydrochlorothiazide on blood lipids. The Oslo Study. Clin Trials J 18: 254–261Google Scholar
  22. 22.
    Levy RL, White PD, Stroud WD et al. (1945) Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129: 585–588Google Scholar
  23. 23.
    MacGregor GA, Markandu ND, Smith SJ, Banks RA, Sagnella GA (1982) Moderate potassium supplementation in essential hypertension. Lancet 2: 567–570PubMedCrossRefGoogle Scholar
  24. 24.
    MacKenzie LF, Shepherd P (1937) The significance of past hypertension in applicants later presenting normal average blood pressures. Proc Ass Life Insur Med Dir Amer 24: 157–178Google Scholar
  25. 25.
    Mathisen HS, Loken H, Brox D et al. (1965) The prognosis in essential hypertension. Scand J Clin Lab Invest 17: 257–261PubMedCrossRefGoogle Scholar
  26. 26.
    Metropolitan Life Insurance Company: Blood pressure: Insurance experience and its implications. (1961) Metropolitan Life Insurance Co., New YorkGoogle Scholar
  27. 27.
    Morgan T, Gillies A, Morgan G, Adam W, Wilson M, Carney S (1978) Hypertension treated by salt restriction. Lancet 1: 227–230PubMedCrossRefGoogle Scholar
  28. 28.
    National High Blood Pressure Education Program. Report of Task Force 1 - Data Base. (1973) DHEW Publication No (NIH) 74–593Google Scholar
  29. 29.
    Overlack A, Stumpe KO (1978) Antihypertensiver Effekt einer fixen Beta-RezeptorenblockerDiuretikum-Kombination bei täglich einmaliger Applikation. Med Welt 29: 1517–1520PubMedGoogle Scholar
  30. 30.
    Priddle W, Liu S, Breithaupt D et al. (1968) Amelioration of high blood pressure in the elderly. J Amer Ger Soc 16: 887–892Google Scholar
  31. 31.
    Reisin E, Abei R, Modan M, Silverberg DS, Elia-hou H, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl J Med 298: 1–6PubMedCrossRefGoogle Scholar
  32. 32.
    Shanks RG (1976) The properties of beta-adrenoceptor antagonists. Postgrad med J 52: 14–20PubMedCrossRefGoogle Scholar
  33. 33.
    Stamler J, Lindberg HA, Berkson DM et al. (1958) Epidemiological analysis of hypertension and hypertensive disease in the labor force of a Chicago utility company. Proc Counc High Blood Press Res 7: 23–52Google Scholar
  34. 34.
    Stamler J, Berkson DM, Dyer A et al. (1975) Relationship of multiple variables to blood pressure. In: Paul O (ed) Epidemiology and Control of Hypertension. Symposia Specialists Miami, p 307Google Scholar
  35. 35.
    Stumpe KO, Kolloch RE (1977) Beta-blocking agents in the treatment of hypertension. Compreh Ther3: 55–65Google Scholar
  36. 36.
    Stumpe KO, Krück F (1982) Beta-adrenerge Rezeptorenblocker oder Diuretika zur Langzeittherapie der arteriellen Hypertension? DMW 107: 363–365CrossRefGoogle Scholar
  37. 37.
    Stumpe KO, Kolloch RE, Vetter H et al. (1976) Acute and long-term studies of the mechanism of action of beta-blocking drugs in lowering blood pressure. Amer J Med 60: 853–865PubMedCrossRefGoogle Scholar
  38. 38.
    Tanaka N, Sakaguchi S, Oshige K et al. (1976) Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 1071–1075PubMedCrossRefGoogle Scholar
  39. 39.
    The Management Committee: The Australian therapeutic trial in mild hypertension. (1980) Lancet 1: 1261–1267Google Scholar
  40. 40.
    Thomas CB, Ross DC, Higgenbottom CQ (1964) Precursors of hypertension and coronary disease among healthy medical students. Discriminant function analysis II using parental history as the criterion Bull Johns Hopkins Hosp 115: 245Google Scholar
  41. 41.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II: Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. (1970)JAMA 213: 1143–1152Google Scholar
  42. 42.
    Waal-Manning HJ (1976) Hypertension: Which criterion. beta-blocker? Drugs 12: 412–441PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • K. O. Stumpe

There are no affiliations available

Personalised recommendations